title: Why China guidelines for type 2 diabetes represent an opportunity for treating this disease.
abstract: More than one quarter of people affected by type 2 diabetes worldwide live in China, where an alarming increase in diabetes incidence is taking place. However, most of the evidence about diabetes management derives from studies conducted on non-Asian people, raising concerns about their validity in other ethnic groups, including the Chinese. The guidelines proposed by the Chinese Diabetes Society suggest tools for medical doctors in China and worldwide to appropriately face diabetes in Chinese people, whose number in non-Chinese countries is continuously increasing. However, additional efforts are still needed to achieve an evidence-based tailored therapy for type 2 diabetes in Chinese people. Copyright © 2016 John Wiley & Sons, Ltd.
authors.affiliation: Department of Medicine, Unit of Endocrinology and Diabetes, University Campus Bio-Medico of Rome, Rome, Italy.
authors.forename: Ernesto
authors.identifier: 0000-0003-3844-9463
authors.initials: E
authors.lastname: Maddaloni
authors.affiliation: Department of Medicine, Unit of Endocrinology and Diabetes, University Campus Bio-Medico of Rome, Rome, Italy.|Centre of Immunobiology, Barts and The London School of Medicine, Queen Mary, University of London, London, UK.
authors.forename: Paolo
authors.initials: P
authors.lastname: Pozzilli
mesh_terms: D002681:China / Q000453:epidemiology; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000628:therapy*; D005006:Ethnicity / Q000706:statistics & numerical data*; D006801:Humans; D015994:Incidence; D017410:Practice Guidelines as Topic / Q000592:standards*